Sarah A. Nickolls - Concepedia

Author

Sarah A. Nickolls

Pfizer (United Kingdom)

Also Known As

Sarah A Nickolls, Sarah A. Nickolls, Sarah Nickolls

Publications

675

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)University of Reading Neurocrine Biosciences (United States)Pfizer (United States)

About

Sarah A. Nickolls is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	99
2	Health Sciences	2	2	67
3	Biochemistry	1	1	39
4	Immunology	1	1	28
5	Molecular Biology	1	1	32

Sarah A. Nickolls

Publications

668

Citations

H-Index

Page 1

	Year	Citations
Functional coupling of the human dopamine D<sub>2</sub> receptor with Gα<sub>i1</sub>, Gα<sub>i2</sub>, Gα<sub>i3</sub> and Gα<sub>o</sub> G proteins: evidence for agonist regulation of G protein selectivity Lucien Gazi, Sarah A. Nickolls, Philip G. Strange British Journal of Pharmacology	2003	94
Molecular Determinants of Melanocortin 4 Receptor Ligand Binding and MC4/MC3 Receptor Selectivity Sarah A. Nickolls, Mary Cismowski, Xiaochuan Wang, Journal of Pharmacology and Experimental Therapeutics	2003	83
Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction Yolande Cordeaux, Sarah A. Nickolls, Lori A. Flood, Journal of Biological Chemistry	2001	68
Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA<sub>A</sub> receptor positive allosteric modulator PF‐06372865 Sarah A. Nickolls, Rachel Gurrell, Guido van Amerongen, British Journal of Pharmacology	2017	59
Functional Selectivity of Melanocortin 4 Receptor Peptide and Nonpeptide Agonists: Evidence for Ligand-Specific Conformational States Sarah A. Nickolls, Beth A. Fleck, Sam R.J. Hoare, Journal of Pharmacology and Experimental Therapeutics	2005	49
Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias Joanne Hothersall, Rubben Torella, Sian Humphreys, Neuropharmacology	2017	47
Understanding the Effect of Different Assay Formats on Agonist Parameters: A Study Using the µ-Opioid Receptor Sarah A. Nickolls, Alison Waterfield, Rachael E. Williams, SLAS DISCOVERY Opioid EpidemicCamp AssaysPharmacotherapyExperimental PharmacologyPharmacodynamic Modeling	2011	39
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate Richard Priestley, Sarah A. Nickolls, S P H Alexander, The FASEB Journal	2014	38
Dimerization of the melanocortin 4 receptor: A study using bioluminescence resonance energy transfer Sarah A. Nickolls, R. Maki Peptides BioluminescenceMelanocortin 4Molecular BiologyLuminescence PropertyExcitation Energy Transfer	2006	32
Design and identification of a novel, functionally subtype selective GABA<sub>A</sub>positive allosteric modulator (PF-06372865). Robert M. Owen, David C. Blakemore, Lishuang Cao, Journal of Medicinal Chemistry	2019	31

Page 1